ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,021Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 682

$1M Total Retail Price of All Prescriptions

Rank: 104 out of 682

562 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 13,377 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 678 463 1 2
METFORMIN HCL 616 390 2 8
LEVOTHYROXINE SODIUM 562 388 3 3
SIMVASTATIN 519 419 4 4
MELOXICAM 498 350 5 27
FUROSEMIDE 497 369 6 7
OMEPRAZOLE 489 302 7 5
NEXIUM 428 267 8 19
AMLODIPINE BESYLATE 399 305 9 6
METOPROLOL TARTRATE 395 349 10 10
GABAPENTIN 345 194 11 9
HYDROCODONE-ACETAMINOPHEN 329 131 S3 12 1
DIOVAN 305 261 13 42
HYDROCHLOROTHIAZIDE 295 196 14 12
ATORVASTATIN CALCIUM 276 186 15 11
POTASSIUM CHLORIDE 247 201 16 14
SERTRALINE HCL 242 136 17 24
AZITHROMYCIN 231 133 18 39
CITALOPRAM HBR 228 144 19 17
ZOLPIDEM TARTRATE 227 127 20 21
WARFARIN SODIUM 219 176 21 13
GLIMEPIRIDE 219 164 21 43
CIPROFLOXACIN HCL 209 151 23 58
DIOVAN HCT 207 155 24 109
CRESTOR 198 151 25 22
CLOPIDOGREL 192 148 26 25
PANTOPRAZOLE SODIUM 174 146 27 29
METOPROLOL SUCCINATE 154 129 28 16
PLAVIX 149 124 29 35
CARVEDILOL 149 111 29 23
ALLOPURINOL 145 113 31 32
DONEPEZIL HCL 144 144 32 30
TIZANIDINE HCL 140 43 33 83
SYNTHROID 138 103 34 59
ATENOLOL 131 79 35 18
AMITRIPTYLINE HCL 127 80 R 36 50
TAMSULOSIN HCL 127 104 36 33
CEFUROXIME 120 81 38 164
TRAZODONE HCL 120 70 38 38
PRAVASTATIN SODIUM 119 94 40 15
RANITIDINE HCL 111 102 41 28
MIRTAZAPINE 109 87 42 52
PAROXETINE HCL 106 51 43 53
CYMBALTA 100 48 44 51
TRAMADOL HCL 94 69 45 26
BUSPIRONE HCL 94 75 45 102
RISPERIDONE 94 67 45 82
PROAIR HFA 92 31 48 45
LANTUS 90 48 49 55
CLONIDINE HCL 87 87 50 48
KLOR-CON M20 86 48 51 67
ROPINIROLE HCL 86 29 51 71
FLUOXETINE HCL 83 52 53 60
NAMENDA 83 83 53 41
DILTIAZEM 24HR CD 82 79 55 123
FLUTICASONE PROPIONATE 78 49 56 36
DEXILANT 77 34 57 201
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 56 57 34
DIGOXIN 75 60 59 46
LOSARTAN-HYDROCHLOROTHIAZIDE 72 65 60 56
GLYBURIDE 72 72 R 60 72
LANSOPRAZOLE 70 36 62 85
LIPITOR 67 45 63 92
IBUPROFEN 67 19 63 79
PROPRANOLOL HCL 65 39 65 141
SINGULAIR 63 49 66 63
DOXEPIN HCL 62 32 67 205
DIVALPROEX SODIUM 61 50 68 84
AMLODIPINE BESYLATE-BENAZEPRIL 60 52 69 77
ADVAIR DISKUS 59 42 70 47
POLYETHYLENE GLYCOL 3350 57 40 71 44
PREMARIN 56 37 R 72 132
AMOXICILLIN 55 35 73 113
COMBIVENT 55 34 73 105
ESCITALOPRAM OXALATE 55 33 73 73
SPIRONOLACTONE 55 49 73 64
DILTIAZEM ER 53 26 77 136
INSULIN SYRINGE 52 20 78 75
ENABLEX 51 46 79 274
CELEBREX 50 37 80 80
JANUVIA 50 47 80 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.